The global continuous glucose monitoring device market is expected to grow with a CAGR of 7.3% from 2025 to 2031. The major drivers for this market are the increasing incidence of prediabetes and increasing prevalence of diabetes globally.
The future of the global continuous glucose monitoring device market looks promising with opportunities in the hospitals and homecare settings markets.
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
The future of the global continuous glucose monitoring device market looks promising with opportunities in the hospitals and homecare settings markets.
- Within the type category, sensors will remain the largest segment over the forecast period.
- Within the application category, hospitals will remain a larger segment.
- In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Continuous Glucose Monitoring Device Market
Continuous glucose monitoring devices have transformed diabetes care by providing real-time insights into blood glucose levels, enabling better disease management and reducing complications. As technology advances and patient demand grows, the CGM market is evolving rapidly with new trends that enhance device accuracy, usability, and integration with broader healthcare systems.- Improved Sensor Accuracy and Longevity: Next-generation CGM sensors offer greater accuracy with reduced calibration needs and longer wear times, enhancing patient convenience and adherence.
- Integration with Digital Health Platforms: Closed-loop systems that combine CGM with insulin pumps (artificial pancreas) are gaining traction, providing automated glucose management. Additionally, CGMs are increasingly linked to smartphone apps and cloud-based platforms for remote monitoring.
- Non-Invasive and Minimally Invasive Technologies: Research and development into non-invasive CGM devices (such as optical sensors) aim to reduce patient discomfort and broaden user adoption.
- Focus on Pediatric and Gestational Diabetes: Specialized CGM solutions tailored for children and pregnant women are emerging, addressing unique management challenges in these populations.
- Wearable and Discreet Device Designs: Smaller, more comfortable, and less visible CGM devices are being developed to enhance patient comfort and social acceptance.
Recent Developments in the Continuous Glucose Monitoring Device Market
The continuous glucose monitoring device market is rapidly evolving as technology advances and the global burden of diabetes increases. Recent developments reflect significant strides in sensor accuracy, device integration, and accessibility, driving broader adoption and improving patient outcomes in diabetes management worldwide.- FDA Approvals for Next-Gen CGM Devices: Several manufacturers, including Dexcom and Abbott, have received FDA approvals for more accurate, longer-lasting CGM systems with reduced calibration requirements, facilitating easier use.
- Integration with Insulin Delivery Systems: The launch of hybrid closed-loop systems that combine CGM with automated insulin pumps (e.g., Tandem Diabetes’ Control-IQ system) marks a major advancement in diabetes care automation.
- Wearable Device Innovations: Manufacturers are introducing smaller, more comfortable, and discreet sensors to enhance patient comfort and compliance.
- New Market Entrants and Collaborations: Startups focusing on non-invasive glucose monitoring and advanced AI analytics have entered the market, forming collaborations with established players to accelerate innovation.
- Regulatory Approvals in Asia-Pacific: Recent clearances by regulatory bodies in China, Japan, and South Korea are facilitating rapid adoption in Asia-Pacific, where diabetes prevalence is rising sharply.
Strategic Growth Opportunities in the Continuous Glucose Monitoring Device Market
The continuous glucose monitoring device market is experiencing rapid expansion driven by rising diabetes prevalence and increasing demand for real-time glucose monitoring solutions. As technology advances and healthcare systems emphasize personalized care, the market presents numerous strategic growth opportunities for manufacturers and stakeholders aiming to enhance diabetes management worldwide.- Expansion into Emerging Markets: Increasing diabetes incidence in Asia-Pacific, Latin America, and Africa offers vast untapped potential. Affordable CGM devices tailored for these regions can significantly boost market penetration.
- Integration with Digital Health and AI Technologies: Leveraging AI and big data analytics to provide predictive insights and personalized treatment plans enhances the value proposition of CGM systems.
- Development of Non-Invasive and Longer-Lasting Sensors: Innovations focusing on non-invasive glucose monitoring and sensors with extended wear time can improve user comfort and adherence.
- Partnerships with Healthcare Providers and Payers: Collaborating with hospitals, insurance companies, and governments to improve reimbursement policies and facilitate device adoption.
- Focus on Pediatric and Special Patient Populations: Creating customized CGM solutions for children, pregnant women, and elderly patients addresses unmet clinical needs and opens niche markets.
Continuous Glucose Monitoring Device Market Drivers and Challenges
Continuous glucose monitoring devices have become essential tools in diabetes management by providing real-time glucose data that helps patients and healthcare providers optimize treatment. While the market is growing rapidly due to technological advancements and rising diabetes prevalence, it also faces certain challenges that could impact widespread adoption.The factors responsible for driving the continuous glucose monitoring device market include:
- Rising Diabetes Prevalence: The global increase in diabetes cases, especially type 1 and insulin-dependent type 2 diabetes, is fueling demand for efficient glucose monitoring solutions.
- Technological Advancements: Improvements in sensor accuracy, longer wear time, and integration with insulin pumps and digital platforms enhance device usability and effectiveness.
- Growing Awareness and Adoption: Increased patient and physician awareness about the benefits of CGM systems over traditional finger-prick testing is driving adoption.
- Supportive Reimbursement Policies: In many developed markets, insurance coverage and government reimbursement programs reduce the financial burden on patients, encouraging device uptake.
- Shift Towards Personalized Diabetes Management: CGM enables tailored treatment approaches, improving patient outcomes and quality of life, which is a significant market driver.
Challenges in the continuous glucose monitoring device market are:
- High Device and Consumable Costs: The relatively high price of CGM devices and sensors limits accessibility, particularly in low- and middle-income countries.
- Limited Insurance Coverage in Emerging Markets: Lack of reimbursement and insurance support in many regions hampers widespread adoption.
- User Compliance and Training: Proper use of CGM devices requires patient education and regular maintenance, which can be a barrier, especially among elderly or less tech-savvy users.
List of Continuous Glucose Monitoring Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies continuous glucose monitoring device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the continuous glucose monitoring device companies profiled in this report include:
- Dexcom, Inc.
- Abbott
- Medtronic
- Ypsomed AG
- Senseonics Holdings
- A. Menarini Diagnostics
- Signos
Continuous Glucose Monitoring Device Market by Segment
The study includes a forecast for the global continuous glucose monitoring device market by type, application, and region.Type [Value from 2019 to 2031]:
- Transmitters
- Sensors
- Receivers
Application [Value from 2019 to 2031]:
- Hospitals
- Homecare Settings
- Others
Country-Wise Outlook for the Continuous Glucose Monitoring Device Market
Continuous glucose monitoring device have revolutionized diabetes management by providing real-time blood glucose readings, helping patients and healthcare providers optimize treatment and reduce complications. With the global rise in diabetes prevalence, demand for CGM systems is growing rapidly. However, market dynamics vary widely across countries due to differences in healthcare infrastructure, awareness, regulatory environments, and reimbursement policies.- United States: The U.S. holds the largest share of the global CGM market, driven by high diabetes prevalence, advanced healthcare infrastructure, and strong reimbursement support from Medicare and private insurers. Leading manufacturers are actively innovating with improved sensor accuracy and integration with insulin pumps, boosting adoption among type 1 and type 2 diabetes patients.
- Germany: Germany represents a key European market with widespread CGM adoption, supported by comprehensive health insurance coverage and increasing physician awareness. Government initiatives encouraging digital health solutions and telemedicine further enhance CGM uptake, especially among younger diabetic populations.
- China: China’s CGM market is rapidly expanding due to rising diabetes incidence and growing patient awareness. While market penetration remains lower than in Western countries, expanding healthcare infrastructure and increasing government focus on chronic disease management are driving investments and local manufacturing initiatives.
- India: India presents a high-growth potential market with a large diabetic population, but CGM adoption is limited by cost sensitivity and lack of widespread insurance coverage. However, increasing diabetes awareness, improving affordability through local device manufacturing, and pilot reimbursement programs are expected to fuel growth in coming years.
- Japan: Japan has a mature CGM market supported by a high standard of healthcare and national health insurance schemes. Emphasis on elderly diabetic care and technological innovation drives steady growth. Japanese companies are also investing in next-generation CGM devices tailored to local patient needs.
Features of this Global Continuous Glucose Monitoring Device Market Report
- Market Size Estimates: Continuous glucose monitoring device market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
- Segmentation Analysis: Continuous glucose monitoring device market size by type, application, and region in terms of value ($B).
- Regional Analysis: Continuous glucose monitoring device market breakdown by North America, Europe, Asia-Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the continuous glucose monitoring device market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the continuous glucose monitoring device market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the continuous glucose monitoring device market by type (transmitters, sensors, and receivers), application (hospitals, homecare settings, and others), and region (North America, Europe, Asia-Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Market Trends & Forecast Analysis
4. Global Continuous Glucose Monitoring Device Market by Type
5. Global Continuous Glucose Monitoring Device Market by Application
6. Regional Analysis
7. North American Continuous Glucose Monitoring Device Market
8. European Continuous Glucose Monitoring Device Market
9. APAC Continuous Glucose Monitoring Device Market
10. RoW Continuous Glucose Monitoring Device Market
11. Competitor Analysis
12. Opportunities & Strategic Analysis
13. Company Profiles of the Leading Players Across the Value Chain
14. Appendix
List of Figures
List of Tables
Companies Mentioned
The companies profiled in this Continuous Glucose Monitoring Device market report include:- Dexcom, Inc.
- Abbott
- Medtronic
- Ypsomed AG
- Senseonics Holdings
- A. Menarini Diagnostics
- Signos
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
